Date published: 2026-3-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

Acenocoumarol (CAS 152-72-7)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
(±)-Acenocoumarin; 3-(α-Acetonyl-p-nitrobenzyl)-4-hydroxy-coumarin
Application:
Acenocoumarol is an anticoagulant vitamin K antagonist
CAS Number:
152-72-7
Purity:
≥98%
Molecular Weight:
353.33
Molecular Formula:
C19H15NO6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Acenocoumarol is a compound that is frequently studied in the context of its effects on the coagulation cascade. It is a vitamin K antagonist that is used in research examining the regulation of blood clotting mechanisms. Studies involving acenocoumarol focus on its role in inhibiting the synthesis of vitamin K-dependent clotting factors, which provides a model for understanding the biochemical pathways involved in coagulation. Additionally, research on this compound explores its dose-response relationship and its impact on the metabolism and function of vitamin K in the liver. In the field of hematology, acenocoumarol is also used to study the management of conditions related to thromboembolism.


Acenocoumarol (CAS 152-72-7) References

  1. [Anticoagulant properties and therapeutic use of a new coumarin derivative: 3-[2-acetyl-1-(p-nitrophenol)-ethyl]-4-hydroxycoumarin or coumarin G 23350].  |  LEROUX, M. and JAMAIN, B. 1956. Therapie. 11: 85-101. PMID: 13337762
  2. Acenocoumarol-induced Henoch-Schönlein purpura.  |  Borrás-Blasco, J., et al. 2004. Ann Pharmacother. 38: 261-4. PMID: 14742763
  3. Cutaneous necrosis induced by acenocoumarol.  |  Valdivielso, M., et al. 2004. J Eur Acad Dermatol Venereol. 18: 211-5. PMID: 15009309
  4. Rosuvastatin-acenocoumarol interaction.  |  Mondillo, S., et al. 2005. Clin Ther. 27: 782-4. PMID: 16117985
  5. Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon.  |  Verhoef, TI., et al. 2014. Br J Clin Pharmacol. 77: 626-41. PMID: 23919835
  6. Acenocoumarol: A Review of Anticoagulant Efficacy and Safety.  |  Trailokya, A., et al. 2016. J Assoc Physicians India. 64: 88-93. PMID: 27730796
  7. IgA vasculitis induced by acenocoumarol.  |  Esteban Terradillos, S., et al. 2020. Reumatol Clin (Engl Ed). 16: 362-363. PMID: 30031735
  8. Hemoptysis Associated With Therapeutic Doses of Acenocoumarol.  |  Cerezo Lajas, A., et al. 2019. Arch Bronconeumol (Engl Ed). 55: 341-342. PMID: 30528810
  9. [Switching from acenocoumarol to phenprocoumon: step in personalised anticoagulation?].  |  van Miert, JHA., et al. 2021. Ned Tijdschr Geneeskd. 165: PMID: 34523845
  10. Biomodification of acenocoumarol by bifidobacteria.  |  Fragomeno, M., et al. 2021. FEMS Microbiol Lett. 368: PMID: 34529059
  11. Acenocoumarol, an Anticoagulant Drug, Prevents Melanogenesis in B16F10 Melanoma Cells.  |  Han, H. and Hyun, C. 2023. Pharmaceuticals (Basel). 16: PMID: 37111361
  12. Absolute configuration of acenocoumarin.  |  Wheeler, CR. and Trager, WF. 1979. J Med Chem. 22: 1122-4. PMID: 490560
  13. Probable acenocoumarol-amoxycillin interaction.  |  Soto, J., et al. 1993. Acta Haematol. 90: 195-7. PMID: 8140860

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Acenocoumarol, 25 mg

sc-217560
25 mg
$191.00